A standardized multidisciplinary approach reduces the use of allogeneic blood products in patients undergoing cardiac surgery

Canadian Journal of Anesthesia

Volumn 48, Issue 9, 2001, Pages 894-901

  Van der Linden, Philippe ^a   De Hert, Stefan ^a   Daper, Anne ^a   Trenchant, Anne ^a   Jacobs, Daniel ^a   De Boelpaepe, Corinne ^a   Kimbimbi, Pierre ^a   Defrance, Pierre ^a   Simoens, Gãtan ^a  

^a Centre Hospitalier Universitaire de Charleroi   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; APROTININ; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FERROUS GLUCONATE; HEMOGLOBIN; HEPARIN;

ADULT; AGED; ARTICLE; BLOOD STORAGE; BLOOD TRANSFUSION; BLOOD VOLUME; CONTROLLED STUDY; CORE TEMPERATURE; ERYTHROCYTE; FEMALE; HEART SURGERY; HEMODILUTION; HEMOGLOBIN DETERMINATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORBIDITY; MORTALITY; POSTOPERATIVE HEMORRHAGE; PREDICTION; PRIORITY JOURNAL; SURGICAL PATIENT; SURGICAL TECHNIQUE;

AGED; APROTININ; BLOOD TRANSFUSION; FEMALE; HEART DISEASES; HEMODILUTION; HEMOSTATICS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE;

EID: 0035215845     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03017357     Document Type: Article

References (36)

1. Comparison of two transfusion strategies after elective operations for myocardial revascularization
2. The variability of transfusion practice in coronary artery bypass surgery
3. Transfusion policies in coronary artery bypass - A nationwide survey in Finland
4. On the need for improved transfusion indicators in cardiac surgery
5. The specific hospital significantly affects red cell and component transfusion practice in coronary artery bypass graft surgery: A study of five hospitals
6. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines
7. Safe and good use of blood in surgery (SANGUIS). Use of blood products and artificial colloids in 43
8. The Belgium BIOMED Study about transfusion for surgery
9. Review of the clinical practice literature on allogeneic red cell transfusion
10. Influence of clinical knowledge, organizational context, and practice style on transfusion decision making. Implications for practice change strategies
11. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation
12. Are there limits to haemodilution?
13. Morbidity and duration of ICU stay after cardiac surgery. A model for preoperative risk assessment
14. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis
15. Intraoperative predonation contributes to blood saving
16. Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion
17. Limiting excessive postoperative blood transfusion after cardiac procedures
18. Transfusion medicine. Second of two parts. Blood transfusion
19. Reduction of allogeneic blood transfusions after open heart operations by lowering cardiopulmonary bypass prime volume
20. Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion as the outcome
21. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints
22. Prevalence of anaphylactic reactions to aprotinin: Analysis of two hundred forty-eight reexposures to aprotinin in heart operations
23. Analysis of coronary graft patency after aprotinin use: Results from the international multicenter aprotinin graft patency experience (IMAGE) trial
24. Aprotinin: Safe and effective only with the full-dose regimen
25. Influence of high- and low-dose aprotinin on activation of hemostasis in open heart operations
26. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty
27. The use of aspirin in ischemic heart disease
28. Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting
29. Aspirin does not increase homologous blood requirements in elective coronary bypass surgery
30. Aspirin does not increase allogeneic blood transfusion in reoperative coronary artery surgery
31. Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting
32. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: Effect on patient outcome
33. The paradox of on-bypass transfusion thresholds in blood conservation
34. Autotransfusion after open heart surgery: Quality of shed mediastinal blood compared to banked blood
35. Autotransfused shed mediastinal blood has normal erythrocyted survival
36. Thromboelastography- guided transfusion algorithm reduces transfusions in complex cardiac surgery